These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 234494)

  • 1. Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.
    Rent R; Ertel N; Eisenstein R; Gewurz H
    J Immunol; 1975 Jan; 114(1 Pt 1):120-4. PubMed ID: 234494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation by interaction of polyanions and polycations.
    Fiedel BA; Rent R; Myhrman R; Gewurz H
    Immunology; 1976 Feb; 30(2):161-9. PubMed ID: 1262050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanious and polycations is the presence of C-reactive protein.
    Claus DR; Siegel J; Petras K; Skor D; Osmand AP; Gewurz H
    J Immunol; 1977 Jan; 118(1):83-7. PubMed ID: 830761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.
    Siegel J; Rent R; Gewurz H
    J Exp Med; 1974 Sep; 140(3):631-47. PubMed ID: 4472155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine hemolytic complement: optimal conditions for its titration.
    Barta O; Barta V
    Am J Vet Res; 1973 May; 34(5):653-7. PubMed ID: 4634064
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modifications of the final stages of the complement reaction by alkali metal cations.
    Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
    J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M; Thesen R
    J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
    Knutzen Steuer KL; Sloan LB; Oglesby TJ; Farries TC; Nickells MW; Densen P; Harley JB; Atkinson JP
    J Immunol; 1989 Oct; 143(7):2256-61. PubMed ID: 2506280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 15. The first component of human complement (C1): kinetics of reaction with its natural substrates.
    Strunk R; Colten HR
    J Immunol; 1974 Mar; 112(3):905-10. PubMed ID: 4811969
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S; Gewurz H; Mold C
    J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.
    Baker PJ; Lint TF; McLeod BC; Behrends CL; Gewurz H
    J Immunol; 1975 Feb; 114(2 Pt 1):554-8. PubMed ID: 1168218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
    Linscott WD
    J Immunol; 1972 Dec; 109(6):1327-36. PubMed ID: 4673616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.